Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Bird flu vaccine approved

  • Comment
The European medicines watchdog has granted marketing authorisation for the first pre-pandemic bird flu vaccine.
Prepandrix, which contains inactivated H5N1 antigens, has been recommended by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

Pre-pandemic vaccines are prepared from influenza viruses with a pandemic potential and are intended for use before a pandemic is declared or during an officially declared pandemic.

The CHMP has also approved Pandemrix, a mock-up H5N1 influenza vaccine, for use during a pandemic. Both vaccines are manufactured by GlaxoSmithKline Biologicals SA.
  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.